Hemophagocytotic syndromes;Sindromes hemofagociticos

Anales Espanoles de Pediatria

Volumn 49, Issue 3, 1998, Pages 230-236

  Herrero Hernandez A ^a,b   Ramirez Jimenez S ^a   Garcia Martin F ^a   Martinez Valverde A ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; CYTOKINE; DEXAMETHASONE; ETOPOSIDE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; PLASMINOGEN ACTIVATOR; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; THROMBOXANE A2; TUMOR NECROSIS FACTOR;

ARTICLE; BLOOD TRANSFUSION; CLINICAL PROTOCOL; DISEASE ASSOCIATION; HEMOPHAGOCYTIC SYNDROME; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MACROPHAGE ACTIVATION; ORAL DRUG ADMINISTRATION; SYNDROME DELINEATION; ADOLESCENT; CHILD; FEMALE; GENETICS; HISTIOCYTOSIS; INFANT; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; REVIEW;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; INFANT; MALE;

EID: 0031768829     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (85)

1. Esseltine DW, De Leeuw NKM, Berry GR. Malignant histiocytosis. Cancer 1983; 52:1904-1910.
2. Favara BE: Hemophagocytic lymphohistiocytosis: A Hemophagocytic Syndrome. Semin in Diagnot Pathol 1992; 9:63-74.
3. Henter J-I. Elinder G, Öst A. The FHL study group of the Histiocyte Society. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncoi 1991; 18:29-33.
4. Farquhar JW, Claireaux AE. Familial hemophagocytic reticulosis. Arch Dis Child 1952; 27:519-525.
5. Hirst WJR, Layton DM, Singh S, Mieli-Vergane G, Chessells JM, Strobel S, Pritchard J: Haemophagocytic lymphohistiocytosis,. Experience at two U.K. centres. British J Hematolog 1994; 88:731-739.
6. Blanche S, Caniglia M, Girault D, Landman J, Griscelli C, Fischer A. Treatment of hemophagocytic lymphohistiocytosis with chemotherapy and bone marrow transplantation: a single center study of 22 cases. Blood 1991; 78:51-54.
7. Henter J-I, Elinder G, Söder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991; 78:2918-2922.
8. Nezelof C.Hemophagocytic lymphohistiocytosis as a syndrome correlation of clinicopathological data. Pediatr Hematol Oncol 1989; 6:207.
9. Sandvig S, Laskay T, Andersson J, De Ley M, Andersson U. Gamma-interferon is produced by CD3+ and 3- lymphocytes Immunol Rev 1987; 97:51.
10. Ijzermans JNM, Marquet RL. Interferon-gamma: a review. Inmunobiology 1989; 179:456.
11. Owen G, Webb DK. Evidence of clonality in a child with haemophagocytic lymphohistiocytosis. Br J Haematol 1995; 89:681-682.
12. Kaneko Y, Maseki N, Sakurai M, Ido M, Tsunematsu Y, Mizutani S, Hattori T, et al. Clonal and non-clonal karyotypically abnormal cells in haemophagocytic lymphohistiocytosis. Br J Haematol 1995; 90:48-55.
13. Wagner R, Morgan G, Strobel S. A prospective study of CD45 isoform expression in haemophagocytic lymphohistiocytosis; an abnormal inheridad inmunophenotype in one family. Clin Exp Immunol 1995; 99:216-220
14. Komp DM, McNamara J, Buckey P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytosis syndromes. Blood 1989; 73:2128.
15. Stephan JL, Zeller J, Hubert PH. Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Pediatr Rheum 1993; 11:451-456.
16. Waage A, Halstensen A, Espevik T. Association Between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; 1:355.
17. Nawroth PP, Stern DM. Modulation of endothelial hostatic properties by tumor necrosis factor. J Exp Med 1986; 163:740.
18. Kist A, Ho AD, Rath U, Wiedernmann D, Bauer A, Schlick E, et al. Decrease of natural killer cell activity and monokine production in peripheral blood of patients treated with recombinant tumor necrosis factor. Blood 1988; 72:344.
19. Koduri PR, Carndang G, DeMarais P, Patel AR. Hyperferritinemia in reactive Hemophagocytic Syndrome. Report of four adult cases. AM J Hematolog 1995; 49:247-249.
20. Coffernils M, Soupart A, Pradier O. Hyperferrtinemia in adult onset still's disease and the hemophagocytic syndrome. J Rheum 1992; 19:1425-1427.
21. Henter J-I, Ehrnst A, Andersson J, Elinder G. Familial hemophagocytic lymphohistiocytosis and viral infections. Acta Paediatr 1993; 82:369-372.
22. Ware R. Human parvovirus infection. Pediatrics 1989; 114:343-348.
23. Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd M, et al. Experimental parvoviral infections in humans. J Infect Dis 1985; 152:257-265.
24. Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 1983; 140:221.
25. Perry MC, Harrison EG, Burget EO, Gilchrist GS. Familial erythrophagocytic lymphohistiocytosis report of two cases and clinicopathologic review. Cancer 1976; 38:209.
26. Ohga S, Matsusaki A, Nishizaki M, Nagashima T, Kai T, Suda M, et al. Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity. Am J Peditr Hematol Oncol 1993; 15:291-298.
27. Fujiwara F, Hibi S, Imashuku S. Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol 1993; 15:92-98.
28. Imashuku S, Hibi S, Todo S. Hemophagocytic lymphohistiocytosis in infancy and childhood. J Pediatr 1997; 130:352-357.
29. Tsui WM, Wong KF, Tse CC- Liver changes in reactive haemophagocytic syndrome. Liver 1992; 12:363-367.
30. a Ed. Barcelona: Mosby-Doyma. 1994-422-436.
31. Fischer A, Virelizier JL, Arenzana-Seisdedos F. Treatment of four patients with erythrophagocytic lymphohistiocytosis by a combination of VP16-213, steroids intrathecal methotrexate and cranial irradiation. Pediatrics 1985; 76:263.
32. Fischer A, Cerf-Bensussan N, Blanche S. Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. J Pediatr 1986; 108:267.
33. Bezanilla JL, Estébanez S, Navajas A, et al. Linfohistiocitosis familiar hemofagocítica (LHFH): Supervivencia de un caso tratado con poliquimioterapia. An Esp Pediatr 1990; 32:368-370.
34. O'Dwyer PJ, Leyland-Jones B, Alonso MT. Etoposide (VP16-213) currents status of an active anticancer drug. N Engl J Med 1985; 312:692.
35. Delaney MM, Shafford EA, Al-Attar A, Pritchard J. Familial erythrophagocytic reticulosis complete response to combination chemotherapy. Arch Dis Child 1984; 28:173.
36. Risdall RJ, McKenna RW, Nesbit ME. Virus-associated haematophagocytic syndrome: a benign histiocytic proliferation distinct from malignant hstiocytosis. Cancer 1979; 44:993-1002.
37. Dalle JH, Dollfus C, Leverger G, Landman-Parker J, Tabone MD, Adam M, et al. Syndrome d'activacion macrophagique chez l'enfant infecté par le VIH. A propos de trois cas. Arch Pediatr 1995; 2:442-446.
38. Majluf-Cruz AS, Hurtado Montoy R, Souto-Meiriño C, Del Río Chiriboga C, Simón J. Síndrome hemofagocítico asociado a histoplasmosis en el síndrome de inmunodeficiencia adquirida: descnpción de tres casos y revision de la literature. Sangre 1993; 38:51-55.
39. Menárguez Palanca J, Tardío Dovao JC, Rábano Gutiérrez A, Izquierdo García F, Palencia Herrejón E. Síndrome hemofagocítico asociado a virus y síndrome de inmunodeficiencia adquirida. Med Clin 1988; 90:506-508.
40. Sugita K, Kurumada H, Eguchi M, Furukawa T. Human herpesvirus 6 infection associated with hemophagocytic syndrome. Acta Haematol 1995; 93:108-109.
41. Shirono K, Tsuda H. Parvovirus B19-asociated haemophagocytic syndrome in healthy adults. Br J Haematolog 1995; 89:923-926.
42. Tsuda H, Maeda Y, Nakagawa K, Nakayama M, Nishimura H, Ishihara A. Parvovirus B 19-associated haemophagocytic syndrome with prominent. Br J Haematolog 1994; 86:413-414.
43. Andreo JA, Vidai JB, Hernández JE, Serrano P, Lopez VM, Soriano J. Sindrome hemofagocítico asociado a brucelosis. Med Clin 1988; 90:502-505.
44. Gutiérrez-Ravé Pecero V, Luque Márquez R, Ayerza Lerchundi M, Cañavate Illescas M, Prados Madrona D. Síndrome hernofagocítico reactivo: análisis de una serie de siete casos. Med Clin 1990; 94:130-134.
45. Ündar L, Karpuzoglu G, Karadogan I, Gelen T, Artvinli M. Tuberculosis-associated haemophagocytic syndrome: a report of two cases and a review of the literature. Acta Haematol 1996; 96:73-78.
46. Lam KY, Ng WF, Chan AC. Miliary tuberculosis with splenic rupture: a fatal case with hemophagocytic syndrome and possible association with long standing sarcoidosis. Pathology 1994; 26:493-496.
47. Gill K, Marrie TJ. Hemophagocytosis secondary to mycopasma pneumoniae infection. Am J Med 1987; 82:668-670.
48. Estrov Z, Bouch R, Shtalrid M, Berrebi A, Restnizky P. Histiocytic hemophagocytosis in Q fever. Arch Pathol Lab Med 1984; 108:77.
49. Iwasaki H, Haschimoto K, Takada N, Nakayama T, Ueda T. Fulminant Richettsia tsutsugamuschi infection associated with haemophagocytic syndrome. Lancet 1994; 343:1236.
50. Mascort Vaca G, Palomera Bernal L, Barcia Ruiz JM. De la Cruz Morgado D, Calvo-Rubio Romero-Portocarrero R, García Díez I, Pedrosa Rivas J. Síndrome histiocito hemofagocitario asociado a una infección por leishmania. An Esp Pediatr 1991; 35:273-275.
51. Betbesé AJ, Ayats R, Pérez M, Rialp G, Ballús J, Mancebo J. Síndrome hemofagocítico asociado a infección por Leishmania donovani. Med Int 1995; 19:432-434.
52. Auerbach M, Haubenstock A, Solomon G. Systemic babesiosis: another cause of the hemophagocytic syndrome. Am J Med 1986; 80:301-303.
53. Keller FG, Kurtzberg J. Disseminated histoplasmosis: a cause of infection-associated hemophagocytic syndrome. Am J Hematol Oncol 1994; 16:368-371.
54. Reiner AP, Spivak JL. Hematophagic histiocytosis. A report of 23 patients and a review of the literature. Medicine 1988; 67:369.
55. Virelizier JL, Lagrue A, Durandy A. Reversal of natural Killer defect in a patient with Chediak-Higaschi Syndrome after bone marrow transplantation. N Engl J Med 1982; 306:1055.
56. Klein C, Philippe N, Le Deist F, Fraitag S, Prost C, Durandy A, et al. Partial albinism with immunodeficiency (Griscclli syndrome). J Pediatr 1994; 125:886-895.
57. Seemayer TA, Gross TG, Egeler RM, Pirruccello SJ, Davis JR, Kelly CM,et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res 1995;38:471-478. Still's disease and the virus-associated haemophagocytic syndrome. Ann Rheum Dis 1985; 44:349-353.
58. Seemayer TA, Gross TG, Egeler RM, Pirruccello SJ, Davis JR, Kelly CM,et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res 1995;38:471-478. Still's disease and the virus-associated haemophagocytic syndrome. Ann Rheum Dis 1985; 44:349-353.
59. Ravelli A, Benedetti F, Viola S, Martini A. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis sucessfully treated with cyclosporine. J Pediair 1996; 128:275-278.
60. Herrero Hernández A, Blasco Ventas A, Oliva Rubio I, Montes de Oca F, Moreno Pacual P, García Martín F, Martínez Valverde A. Síndrome de activación del macrófago en artritis crónica juvenil forma sistémica. Arch Pediatr 1997; 48:195-201.
61. Heaton DC, Moller PW. Still's disease associated with coxsackie infection and haemophagocytic syndrome. Ann Rheum Dis 1985; 44:341-344.
62. Moms JA, Adamson AR, Holt PJ, Davson J. Med 1986; 80:301-303.
63. McPeake JR, Hirst WJ, Brind AM, Williams R. Hepatitis A causing a second episode of virus-associated haemophagocytic lymphohistiocytosis in a patient with Still's disease. J Med Virol 1993; 39;173-175.
64. Stephan J-I, Zeller J, Hubert P, Herbelin C, Dayer J-M, Prieur A-M. Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 1993; 11:451-456.
65. Fishman D, Rooney M, Woo P. Successful mangement of reactive hamophagocytic syndrome in systemic-onset juvenile chronic arthritis. Br J Rheumatol 1995; 34:888-893.
66. Bray VJ, Singleton JD. Disseminated Intravascular Coagulation in Still's Disease. Semin Arthritis Rheum 1994; 24:222-229.
67. Wong Kf, Hui PK, Chan JKC. The Acute Lupus Hemophagocytyc Syndrome. Am Inter Med 1991; 114:387-390.
68. Ohga S, Ooshima A, Fukuschige J, Ueda K. Histiocytic haemophagocytosis in a patient with kawasaki disease: changes in the hypercytokinaemic state. Eur J Pediatr 1995; 154:539-541.
69. Domingo-Claros A, Alonso E, Eventin A, Petit J, Crespo N, Ponce C. Oligoblastic leukaemia with (8;21) translocation and haemophagocytic syndrome and granulocytic cannibalism. Leuk Res 1996; 20:517-521.
70. Campbell JK, Mitchell CA. Immune thrombocytopenia in association with acute lymphoblastic leukaemia and a haemophagocytic syndrome. Eur J Haemoatolog 1993; 51:259-261.
71. Nakamoto T, Ogawa S, Mano H, Hirai H, Yazaki Y. Haemophagocytic syndrome associated with non-Hodgkin's lymphoma of B-cell type. Am J Hematol 1994; 47;335-336.
72. Linn YC, Tien SL, Lim LC, Lee LH, Teoh G, Goh YT, et al. Haemophagocytosis in bone marrow aspirate A review of the clinical course of 10 cases. Acta Haematol 1995; 94;182-191.
73. Pringle JH, Primrose L, Myint SH. The presence of Epstein-Barr virus in multiple organs in a fatal case of virus-associated haemophagocytic syndrome. J Infect 1995; 31:159-160.
74. Ishihara S, Okada S, Wakiguchi H, Kuraschige T, Morischima T, Kawa-Ha K. Chronic active Epstein-Barr virus infection in children in Japan. Acta Paediatr 1995; 84:1271-1275.
75. Yao M, Cheng AL, Su I-J, Lin MT, Uen W-C, Tien H-F, et al. Clinicopathological spectrum of haemophagocytic syndrome in Epstein-Barr virus-associated peripheral T-cell lymphoma. Br J Haematolog 1994; 87:535-543.
76. Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM. Efficacy of cyclosporine A in the tratment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 1996; 129:750-754.
77. Shiroco K, Tsuda H. Virus-associated haemophagocytic syndrome in previusly healthy adults. Eur J Haematol 1995; 55:240-244.
78. Kondo H, Date Y. Effects of simultaneous rhG-CSF and methylprednisolone "pulse" therapy on hepatitis A virus-associated haemophagocytic syndrome. Eur J Haematol 1995; 54:271-273.
79. Tsuda H, Shirono K. Successful treatment of virus-associated haemophagocytic syndrome in adults by cyclosporin A suppurted by granulocyte colony-stimulating factor. Br J Haematol 1996; 93:572-575.
80. Oyama Y, Amano T, Hirakawa S, Hironaka K, Suzuki S, Ota Z. Haemophagocytic syndrome treated with cyclosporin A: a T-cell disorder. Br J Haematolog 1989; 73:276-278.
81. Imashuku S, Hibi S. Cytokines in haemophagocytic syndrome. Br J Haematolog 1991; 77:438-440.
82. Watson HG, Goulden NJ, Manson LM, McDermid G, Gray JA, Parker AC. Virus associated haemophagocytic syndrome. further evidence for a T-cell mediated disorder. Br J Haematolog 1994; 86:213-215.
83. Gill DS, Spencer A, Cobcroft G. High-dose gamma-globulin therapy in the reactive haemophagocytic syndrome. Br J Haematolog 1994; 88:204-206.
84. Freeman B, Rathore MH, Salman E, Joyce MJ, Pitel P. Intravenusly administered immune globulin for the treatment of infection-associated hemophagocytic syndrome. J Pediatr 1993; 123:479-481.
85. Smith KJ, Skelton HG, Giblin WL, James WD. Cutaneus lesions of hemophagocytic syndrome in a patient with t-cell lymphoma and active Epstein-Barr infection. J Am Acad Dermatol 1991; 25:919-924.